• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

• Clarivate Analytics to Acquire Decision Resources for $950m (2020-01-17)
  > Deal expands Life Sciences services and solutions portfolio to enable customers worldwide to accelerate life-changing innovations and improve patient outcomes and access > Accretive to earnings in 2020 with opportunities for significant revenue and cost syner...
• Charles River Labs & Fios Genomics Form a Strategic Alliance (2020-01-16)
  Together, Charles River and Fios Genomics aim to accelerate preclinical discovery and development by turning complex data into actionable information Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusi...
• Astellas & Adpaptimmune: Allogenic T-Cell Therapies (2020-01-14)
  - Agreement covers the co-development and co-commercialization of up to three T-cell therapies - - Agreement leverages Astellas’ Universal Donor Cell Platform and Adaptimmune’s stem-cell derived allogeneic T-cell platform - - Astellas will pay Adaptimmune an ...
• UK Hearing Medicines Discovery Syndicate Launches (2020-01-09)
  Today (9th January 2020), the charity Action on Hearing Loss and Medicines Discovery Catapult announce the launch of the Hearing Medicines Discovery Syndicate, a unique collaboration to accelerate the much-needed development of treatments for hearing loss and tinni...
• Alderaan Biotechnology: €18.5m Series A from AFB & Medicxi (2020-01-09)
  Funding will help develop technologies to deplete Treg cells in cancer and boost NK cell cytotoxic activity Alderaan Biotechnology, a preclinical stage company focused on monoclonal antibodies development for the treatment of cancer, announces today the succes...
• Grey Wolf Completes £2.5m Series A2 Financing (2020-01-09)
  Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumors for attack and destruction by the immune system Grey Wolf Therapeutics, a drug discovery biotechnology company focused on developing first-in-class therap...
• Emergex Vaccines Raises $11m Series A Round (2020-01-09)
  > Emergex develops set-point vaccines to prevent some of the world’s most immediate and virulent diseases such as Zika, Dengue Fever, Ebola and pandemic Flu > Vickers Venture Partners led the fundraising and Dr Finian Tan, Chairman of Vickers Venture Partners jo...
• Bayer & Exscientia to Leverage AI for Drug Discovery (2020-01-09)
  Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia’s proprietary AI drug discovery plat...
• Avacta & Daewoong Pharma Form Immunotherapy Joint Venture (2020-01-08)
  Joint Venture to develop next generation cell and gene therapies incorporating Affimer proteins Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and Daewoong Pharmaceutical Co. Ltd., (KSX: 069620), a leading Korean pharmace...
• Deborah Waterhouse Joins GSK Corporate Executive Team (2020-01-08)
  GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Deborah Waterhouse, CEO of global specialist HIV company ViiV Healthcare, will join GSK’s Corporate Executive Team (CET) with immediate effect. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and S...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations


in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

Start here with the latest News!

Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.